nodes	percent_of_prediction	percent_of_DWPC	metapath
Piroxicam—osteoarthritis—Prednisone—Crohn's disease	0.279	1	CpDpCtD
Piroxicam—Sulfapyridine—Sulfasalazine—Crohn's disease	0.209	1	CrCrCtD
Piroxicam—PTGS2—Crohn's disease	0.107	0.529	CbGaD
Piroxicam—ALB—Crohn's disease	0.0953	0.471	CbGaD
Piroxicam—PTGS2—Balsalazide—Crohn's disease	0.0585	0.202	CbGbCtD
Piroxicam—PTGS1—Balsalazide—Crohn's disease	0.0494	0.171	CbGbCtD
Piroxicam—PTGS2—Mesalazine—Crohn's disease	0.0467	0.162	CbGbCtD
Piroxicam—PTGS1—Mesalazine—Crohn's disease	0.0395	0.136	CbGbCtD
Piroxicam—SLC22A8—Mercaptopurine—Crohn's disease	0.0341	0.118	CbGbCtD
Piroxicam—PTGS2—Sulfasalazine—Crohn's disease	0.0261	0.0902	CbGbCtD
Piroxicam—PTGS1—Sulfasalazine—Crohn's disease	0.0221	0.0762	CbGbCtD
Piroxicam—ALB—Prednisone—Crohn's disease	0.0132	0.0455	CbGbCtD
Piroxicam—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.0015	0.0783	CbGpPWpGaD
Piroxicam—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.0015	0.0783	CbGpPWpGaD
Piroxicam—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00114	0.0597	CbGpPWpGaD
Piroxicam—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00114	0.0597	CbGpPWpGaD
Piroxicam—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.000952	0.0498	CbGpPWpGaD
Piroxicam—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.000952	0.0498	CbGpPWpGaD
Piroxicam—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX4—Crohn's disease	0.000828	0.0433	CbGpPWpGaD
Piroxicam—Lornoxicam—PTGS2—Crohn's disease	0.000485	0.354	CrCbGaD
Piroxicam—Tenoxicam—PTGS2—Crohn's disease	0.000432	0.315	CrCbGaD
Piroxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—CREM—Crohn's disease	0.000378	0.0198	CbGpPWpGaD
Piroxicam—Meloxicam—PTGS2—Crohn's disease	0.000308	0.225	CrCbGaD
Piroxicam—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.0003	0.0157	CbGpPWpGaD
Piroxicam—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.0003	0.0157	CbGpPWpGaD
Piroxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—Crohn's disease	0.000268	0.014	CbGpPWpGaD
Piroxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CREM—Crohn's disease	0.000245	0.0128	CbGpPWpGaD
Piroxicam—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000228	0.012	CbGpPWpGaD
Piroxicam—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000228	0.012	CbGpPWpGaD
Piroxicam—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.000205	0.0107	CbGpPWpGaD
Piroxicam—PTGS1—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000191	0.01	CbGpPWpGaD
Piroxicam—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000191	0.00998	CbGpPWpGaD
Piroxicam—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000191	0.00998	CbGpPWpGaD
Piroxicam—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000187	0.00977	CbGpPWpGaD
Piroxicam—PTGS1—Overview of nanoparticle effects—CRP—Crohn's disease	0.000166	0.00871	CbGpPWpGaD
Piroxicam—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.000163	0.00852	CbGpPWpGaD
Piroxicam—PTGS2—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000152	0.00795	CbGpPWpGaD
Piroxicam—Oxcarbazepine—ALB—Crohn's disease	0.000146	0.107	CrCbGaD
Piroxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL3—Crohn's disease	0.000142	0.00746	CbGpPWpGaD
Piroxicam—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—Crohn's disease	0.000142	0.00745	CbGpPWpGaD
Piroxicam—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000142	0.00745	CbGpPWpGaD
Piroxicam—SLC22A11—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000136	0.00712	CbGpPWpGaD
Piroxicam—SLC22A11—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000136	0.00712	CbGpPWpGaD
Piroxicam—PTGS2—Overview of nanoparticle effects—CRP—Crohn's disease	0.000132	0.00691	CbGpPWpGaD
Piroxicam—CYP2C8—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000124	0.00647	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—GPX4—Crohn's disease	0.000122	0.00637	CbGpPWpGaD
Piroxicam—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000119	0.00622	CbGpPWpGaD
Piroxicam—PTGS1—Overview of nanoparticle effects—PTGS2—Crohn's disease	0.000112	0.00584	CbGpPWpGaD
Piroxicam—PTGS1—Overview of nanoparticle effects—CXCL8—Crohn's disease	0.000108	0.00566	CbGpPWpGaD
Piroxicam—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000104	0.00543	CbGpPWpGaD
Piroxicam—SLC22A8—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000104	0.00543	CbGpPWpGaD
Piroxicam—CYP2C9—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000101	0.00526	CbGpPWpGaD
Piroxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Crohn's disease	9.98e-05	0.00523	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—GPX4—Crohn's disease	9.84e-05	0.00515	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—GPX4—Crohn's disease	9.66e-05	0.00506	CbGpPWpGaD
Piroxicam—SLC22A11—SLC-mediated transmembrane transport—GCKR—Crohn's disease	9.59e-05	0.00502	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—MPO—Crohn's disease	9.28e-05	0.00486	CbGpPWpGaD
Piroxicam—PTGS1—Eicosanoid Synthesis—PTGS2—Crohn's disease	9.25e-05	0.00484	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—MPO—Crohn's disease	9.22e-05	0.00483	CbGpPWpGaD
Piroxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—Crohn's disease	9.22e-05	0.00482	CbGpPWpGaD
Piroxicam—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	8.66e-05	0.00454	CbGpPWpGaD
Piroxicam—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	8.66e-05	0.00454	CbGpPWpGaD
Piroxicam—PTGS2—Overview of nanoparticle effects—CXCL8—Crohn's disease	8.59e-05	0.0045	CbGpPWpGaD
Piroxicam—ALB—Platelet degranulation—F5—Crohn's disease	8.54e-05	0.00447	CbGpPWpGaD
Piroxicam—SLC22A11—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	8.48e-05	0.00444	CbGpPWpGaD
Piroxicam—ALB—Response to elevated platelet cytosolic Ca2+—F5—Crohn's disease	8.13e-05	0.00426	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—GPX4—Crohn's disease	7.82e-05	0.00409	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	7.79e-05	0.00408	CbGpPWpGaD
Piroxicam—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	7.74e-05	0.00405	CbGpPWpGaD
Piroxicam—PTGS2—C-MYB transcription factor network—MPO—Crohn's disease	7.64e-05	0.004	CbGpPWpGaD
Piroxicam—PTGS1—Overview of nanoparticle effects—TNF—Crohn's disease	7.53e-05	0.00394	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—MPO—Crohn's disease	7.5e-05	0.00393	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—MPO—Crohn's disease	7.37e-05	0.00386	CbGpPWpGaD
Piroxicam—SLC22A8—SLC-mediated transmembrane transport—GCKR—Crohn's disease	7.31e-05	0.00383	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	6.92e-05	0.00362	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	6.92e-05	0.00362	CbGpPWpGaD
Piroxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Crohn's disease	6.58e-05	0.00345	CbGpPWpGaD
Piroxicam—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	6.46e-05	0.00338	CbGpPWpGaD
Piroxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Crohn's disease	6.46e-05	0.00338	CbGpPWpGaD
Piroxicam—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	6.1e-05	0.0032	CbGpPWpGaD
Piroxicam—PTGS1—Overview of nanoparticle effects—IL6—Crohn's disease	6.08e-05	0.00318	CbGpPWpGaD
Piroxicam—PTGS2—Overview of nanoparticle effects—TNF—Crohn's disease	5.98e-05	0.00313	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—MPO—Crohn's disease	5.96e-05	0.00312	CbGpPWpGaD
Piroxicam—PTGS2—C-MYB transcription factor network—TAB1—Crohn's disease	5.76e-05	0.00301	CbGpPWpGaD
Piroxicam—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	5.4e-05	0.00282	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	5.27e-05	0.00276	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	5.27e-05	0.00276	CbGpPWpGaD
Piroxicam—PTGS1—Arachidonic acid metabolism—PTGS2—Crohn's disease	5.14e-05	0.00269	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—CRP—Crohn's disease	4.88e-05	0.00255	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.87e-05	0.00255	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—CRP—Crohn's disease	4.85e-05	0.00254	CbGpPWpGaD
Piroxicam—PTGS2—Overview of nanoparticle effects—IL6—Crohn's disease	4.82e-05	0.00253	CbGpPWpGaD
Piroxicam—CYP2C8—Metapathway biotransformation—GPX4—Crohn's disease	4.53e-05	0.00237	CbGpPWpGaD
Piroxicam—ALB—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	4.5e-05	0.00236	CbGpPWpGaD
Piroxicam—ALB—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	4.5e-05	0.00236	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—ICAM1—Crohn's disease	4.49e-05	0.00235	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—ICAM1—Crohn's disease	4.46e-05	0.00233	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	4.41e-05	0.00231	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	4.4e-05	0.0023	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	4.4e-05	0.0023	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.31e-05	0.00225	CbGpPWpGaD
Piroxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Crohn's disease	4.26e-05	0.00223	CbGpPWpGaD
Piroxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Crohn's disease	3.96e-05	0.00207	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—CRP—Crohn's disease	3.95e-05	0.00207	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—CRP—Crohn's disease	3.87e-05	0.00203	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—F5—Crohn's disease	3.79e-05	0.00198	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.75e-05	0.00196	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—ALB—Crohn's disease	3.74e-05	0.00196	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.72e-05	0.00195	CbGpPWpGaD
Piroxicam—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	3.69e-05	0.00193	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—ICAM1—Crohn's disease	3.63e-05	0.0019	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—ICAM1—Crohn's disease	3.56e-05	0.00186	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.5e-05	0.00183	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—IFNG—Crohn's disease	3.41e-05	0.00179	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—IFNG—Crohn's disease	3.39e-05	0.00178	CbGpPWpGaD
Piroxicam—CYP2C8—Arachidonic acid metabolism—PTGS2—Crohn's disease	3.32e-05	0.00174	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.29e-05	0.00172	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—PTGS2—Crohn's disease	3.27e-05	0.00171	CbGpPWpGaD
Piroxicam—ALB—SLC-mediated transmembrane transport—GCKR—Crohn's disease	3.17e-05	0.00166	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	3.15e-05	0.00165	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—CRP—Crohn's disease	3.13e-05	0.00164	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.1e-05	0.00162	CbGpPWpGaD
Piroxicam—SLC22A11—SLC-mediated transmembrane transport—ALB—Crohn's disease	3.05e-05	0.0016	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—IL1B—Crohn's disease	3.04e-05	0.00159	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—IL1B—Crohn's disease	3.03e-05	0.00158	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.97e-05	0.00156	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—ALB—Crohn's disease	2.97e-05	0.00155	CbGpPWpGaD
Piroxicam—PTGS2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	2.95e-05	0.00154	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—TLR4—Crohn's disease	2.94e-05	0.00154	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.92e-05	0.00153	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—ICAM1—Crohn's disease	2.88e-05	0.00151	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.85e-05	0.00149	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.83e-05	0.00148	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—ICAM1—Crohn's disease	2.82e-05	0.00147	CbGpPWpGaD
Piroxicam—ALB—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	2.8e-05	0.00147	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—IFNG—Crohn's disease	2.76e-05	0.00144	CbGpPWpGaD
Piroxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	2.76e-05	0.00144	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.74e-05	0.00144	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.73e-05	0.00143	CbGpPWpGaD
Piroxicam—PTGS2—C-MYB transcription factor network—CD4—Crohn's disease	2.72e-05	0.00142	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—IFNG—Crohn's disease	2.71e-05	0.00142	CbGpPWpGaD
Piroxicam—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	2.7e-05	0.00142	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—IL1B—Crohn's disease	2.46e-05	0.00129	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.42e-05	0.00127	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—IL1B—Crohn's disease	2.42e-05	0.00127	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.41e-05	0.00126	CbGpPWpGaD
Piroxicam—SLC22A8—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.33e-05	0.00122	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.32e-05	0.00121	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.32e-05	0.00121	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	2.29e-05	0.0012	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	2.29e-05	0.0012	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—IL3—Crohn's disease	2.27e-05	0.00119	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—TNF—Crohn's disease	2.21e-05	0.00116	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	2.2e-05	0.00115	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—TNF—Crohn's disease	2.2e-05	0.00115	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—IFNG—Crohn's disease	2.19e-05	0.00115	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.17e-05	0.00114	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—IFNG—Crohn's disease	2.14e-05	0.00112	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—PTGS2—Crohn's disease	2.1e-05	0.0011	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	1.99e-05	0.00104	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.97e-05	0.00103	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—PLA2G4F—Crohn's disease	1.96e-05	0.00103	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—IL1B—Crohn's disease	1.96e-05	0.00102	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—F5—Crohn's disease	1.95e-05	0.00102	CbGpPWpGaD
Piroxicam—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.94e-05	0.00102	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	1.91e-05	0.001	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.89e-05	0.000987	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.87e-05	0.000982	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—TNF—Crohn's disease	1.79e-05	0.000935	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	1.78e-05	0.000933	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—IL6—Crohn's disease	1.77e-05	0.000927	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.77e-05	0.000924	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.76e-05	0.000919	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	1.75e-05	0.000918	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—MTMR3—Crohn's disease	1.67e-05	0.000874	CbGpPWpGaD
Piroxicam—PTGS2—Disease—RSPO3—Crohn's disease	1.63e-05	0.000851	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.61e-05	0.000844	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	1.59e-05	0.000833	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—PLA2G4F—Crohn's disease	1.56e-05	0.000816	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—ALB—Crohn's disease	1.55e-05	0.000812	CbGpPWpGaD
Piroxicam—PTGS2—Disease—SEL1L—Crohn's disease	1.54e-05	0.000807	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.53e-05	0.000803	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—IL6—Crohn's disease	1.44e-05	0.000754	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.44e-05	0.000752	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.43e-05	0.000746	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	1.42e-05	0.000743	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	1.42e-05	0.000741	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	1.39e-05	0.000726	CbGpPWpGaD
Piroxicam—PTGS2—Disease—LTF—Crohn's disease	1.38e-05	0.000724	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—MTMR3—Crohn's disease	1.32e-05	0.000694	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—FADS1—Crohn's disease	1.3e-05	0.000681	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	1.27e-05	0.000664	CbGpPWpGaD
Piroxicam—ALB—Metabolism—PLA2G4F—Crohn's disease	1.26e-05	0.00066	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—GPX4—Crohn's disease	1.22e-05	0.000637	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—ITGA4—Crohn's disease	1.2e-05	0.000628	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—ALB—Crohn's disease	1.18e-05	0.000619	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—GCKR—Crohn's disease	1.18e-05	0.000615	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—IL3—Crohn's disease	1.17e-05	0.000613	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	1.14e-05	0.000599	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—RASGRP1—Crohn's disease	1.13e-05	0.000593	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	1.12e-05	0.000586	CbGpPWpGaD
Piroxicam—PTGS2—Disease—GCKR—Crohn's disease	1.11e-05	0.000583	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—MTMR3—Crohn's disease	1.08e-05	0.000564	CbGpPWpGaD
Piroxicam—ALB—Metabolism—MTMR3—Crohn's disease	1.07e-05	0.000561	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	1.07e-05	0.00056	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—FADS1—Crohn's disease	1.03e-05	0.00054	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	1.03e-05	0.00054	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	9.87e-06	0.000517	CbGpPWpGaD
Piroxicam—PTGS2—Disease—SLC11A1—Crohn's disease	9.85e-06	0.000516	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—GPX4—Crohn's disease	9.66e-06	0.000506	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	9.43e-06	0.000494	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—GCKR—Crohn's disease	9.33e-06	0.000489	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—MTMR3—Crohn's disease	8.77e-06	0.000459	CbGpPWpGaD
Piroxicam—PTGS2—Disease—RBX1—Crohn's disease	8.45e-06	0.000442	CbGpPWpGaD
Piroxicam—PTGS2—Disease—HSPA1B—Crohn's disease	8.45e-06	0.000442	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	8.4e-06	0.00044	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—FADS1—Crohn's disease	8.4e-06	0.00044	CbGpPWpGaD
Piroxicam—ALB—Metabolism—FADS1—Crohn's disease	8.35e-06	0.000437	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—IL2RA—Crohn's disease	8.2e-06	0.000429	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—GPX4—Crohn's disease	7.86e-06	0.000412	CbGpPWpGaD
Piroxicam—ALB—Metabolism—GPX4—Crohn's disease	7.82e-06	0.000409	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—GCKR—Crohn's disease	7.59e-06	0.000398	CbGpPWpGaD
Piroxicam—ALB—Metabolism—GCKR—Crohn's disease	7.55e-06	0.000395	CbGpPWpGaD
Piroxicam—PTGS2—Disease—UBE2D1—Crohn's disease	7.41e-06	0.000388	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	7.35e-06	0.000385	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—FADS1—Crohn's disease	6.83e-06	0.000358	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.67e-06	0.000349	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—GPX4—Crohn's disease	6.4e-06	0.000335	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—GCKR—Crohn's disease	6.18e-06	0.000324	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—JAK2—Crohn's disease	5.51e-06	0.000288	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.43e-06	0.000284	CbGpPWpGaD
Piroxicam—PTGS2—Disease—SMAD3—Crohn's disease	5.3e-06	0.000277	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.75e-06	0.000249	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.72e-06	0.000247	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.42e-06	0.000231	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.86e-06	0.000202	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—ALB—Crohn's disease	3.74e-06	0.000196	CbGpPWpGaD
Piroxicam—PTGS2—Disease—TYK2—Crohn's disease	3.46e-06	0.000181	CbGpPWpGaD
Piroxicam—PTGS2—Disease—JAK2—Crohn's disease	3.3e-06	0.000173	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—PTGS2—Crohn's disease	3.27e-06	0.000171	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CD4—Crohn's disease	3.13e-06	0.000164	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—ALB—Crohn's disease	2.97e-06	0.000156	CbGpPWpGaD
Piroxicam—PTGS2—Disease—STAT3—Crohn's disease	2.42e-06	0.000127	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—ALB—Crohn's disease	2.42e-06	0.000127	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—PTGS2—Crohn's disease	2.11e-06	0.000111	CbGpPWpGaD
Piroxicam—ALB—Metabolism—PTGS2—Crohn's disease	2.1e-06	0.00011	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—ALB—Crohn's disease	1.97e-06	0.000103	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PTGS2—Crohn's disease	1.72e-06	9.01e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—IL6—Crohn's disease	1.69e-06	8.85e-05	CbGpPWpGaD
